<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6266983</article-id><article-id pub-id-type="doi">10.3390/nu10111727</article-id><article-id pub-id-type="publisher-id">nutrients-10-01727</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Gluten-Free Diet and Its &#x02018;Cousins&#x02019; in Irritable Bowel Syndrome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rej</surname><given-names>Anupam</given-names></name><xref ref-type="aff" rid="af1-nutrients-10-01727">1</xref></contrib><contrib contrib-type="author"><name><surname>Sanders</surname><given-names>David Surendran</given-names></name><xref ref-type="aff" rid="af1-nutrients-10-01727">1</xref><xref ref-type="aff" rid="af2-nutrients-10-01727">2</xref><xref rid="c1-nutrients-10-01727" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-nutrients-10-01727"><label>1</label>Academic Unit of Gastroenterology, Royal Hallamshire Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield S10 2JF, UK; <email>anupam.rej@sth.nhs.uk</email></aff><aff id="af2-nutrients-10-01727"><label>2</label>Academic Unit of Gastroenterology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK</aff><author-notes><corresp id="c1-nutrients-10-01727"><label>*</label>Correspondence: <email>david.sanders@sth.nhs.uk</email>; Tel.: +0114-226-1179</corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2018</year></pub-date><volume>10</volume><issue>11</issue><elocation-id>1727</elocation-id><history><date date-type="received"><day>11</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>08</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Functional disorders are common, with irritable bowel syndrome (IBS) being the commonest and most extensively evaluated functional bowel disorder. It is therefore paramount that effective therapies are available to treat this common condition. Diet appears to play a pivotal role in symptom generation in IBS, with a recent interest in the role of dietary therapies in IBS. Over the last decade, there has been a substantial increase in awareness of the gluten-free diet (GFD), with a recent focus of the role of a GFD in IBS. There appears to be emerging evidence for the use of a GFD in IBS, with studies demonstrating the induction of symptoms following gluten in patients with IBS. However, there are questions with regards to which components of wheat lead to symptom generation, as well as the effect of a GFD on nutritional status, gut microbiota and long-term outcomes. Further studies are required, although the design of dietary studies remain challenging. The implementation of a GFD should be performed by a dietitian with a specialist interest in IBS, which could be achieved via the delivery of group sessions.</p></abstract><kwd-group><kwd>non-coeliac gluten sensitivity</kwd><kwd>gluten</kwd><kwd>wheat</kwd><kwd>low FODMAP diet</kwd><kwd>irritable bowel syndrome</kwd></kwd-group></article-meta></front><body><sec id="sec1-nutrients-10-01727"><title>1. Introduction</title><p>Functional disorders are common, with the Rome IV guidelines classifying these disorders into oesophageal, gastroduodenal, bowel, centrally mediated, anorectal, gallbladder, and sphincter of Oddi disorders [<xref rid="B1-nutrients-10-01727" ref-type="bibr">1</xref>]. The commonest and most extensively evaluated functional bowel disorder is irritable bowel syndrome (IBS), with a reported global pooled prevalence of 11 percent [<xref rid="B2-nutrients-10-01727" ref-type="bibr">2</xref>]. IBS can be classified into diarrhoea-predominant (IBS-D), constipation-predominant (IBS-C), mixed (IBS-M) and unclassified (IBS-U) [<xref rid="B1-nutrients-10-01727" ref-type="bibr">1</xref>]. The pathophysiology of IBS is not fully understood, but several pathophysiological mechanisms have been proposed, including visceral hypersensitivity, inflammation, increased intestinal mucosal permeability, and genetic and psychological factors [<xref rid="B3-nutrients-10-01727" ref-type="bibr">3</xref>,<xref rid="B4-nutrients-10-01727" ref-type="bibr">4</xref>]. The impact of IBS can lead to a significant impact on sufferers, with a reduced quality of life, increased time off work and greater utilisation of healthcare [<xref rid="B5-nutrients-10-01727" ref-type="bibr">5</xref>]. It is also associated with several other conditions such as depression, fibromyalgia, chronic fatigue disorder, and temporomandibular joint disorder [<xref rid="B6-nutrients-10-01727" ref-type="bibr">6</xref>]. As a result of this, it is paramount that there are effective treatments for this common condition.</p><p>Despite many individuals using medication for the treatment of functional disorders, up to two-thirds of individuals with functional disorders also use diet or dietary supplements as a therapy [<xref rid="B7-nutrients-10-01727" ref-type="bibr">7</xref>]. A large proportion of individuals with IBS note that they have dietary triggers, with up to two-thirds of individuals noting the induction of symptoms after ingestion of food [<xref rid="B8-nutrients-10-01727" ref-type="bibr">8</xref>,<xref rid="B9-nutrients-10-01727" ref-type="bibr">9</xref>,<xref rid="B10-nutrients-10-01727" ref-type="bibr">10</xref>]. As a result of this, there has been great interest in the role of dietary therapies in IBS, with a focus recently in a low fermentable oligo-, di-, and mono-saccharides and polyols (FODMAPs) diet, wheat free diet (WFD) and gluten-free diet (GFD).</p><p>There has been an increase in the awareness of the GFD over the last decade [<xref rid="B11-nutrients-10-01727" ref-type="bibr">11</xref>], with the gluten-free food industry continuing to rise, with more than $15 billion dollars spent in the USA in 2016 [<xref rid="B12-nutrients-10-01727" ref-type="bibr">12</xref>]. Whilst GFDs are known as the mainstay of treatment for people with an established diagnosis of coeliac disease [<xref rid="B13-nutrients-10-01727" ref-type="bibr">13</xref>], we will explore the emerging evidence for this dietary therapy in individuals with IBS.</p></sec><sec id="sec2-nutrients-10-01727"><title>2. Wheat Free Diet</title><p>Gluten is found in the endosperm of grass-related grains, including wheat, barley, and rye. In view of this, it is important to explore the role of a WFD in IBS as many individuals consuming a GFD maybe avoiding wheat.</p><p>Wheat avoidance is common, with a cross-sectional population survey in Australia reporting wheat avoidance in approximately 10% of individuals [<xref rid="B14-nutrients-10-01727" ref-type="bibr">14</xref>]. A significant proportion of individuals with IBS who reduce wheat consumption may have a wheat sensitivity. A large study [<xref rid="B15-nutrients-10-01727" ref-type="bibr">15</xref>], in which 920 patients with IBS who had a self-reduced wheat consumption, underwent an elimination diet for 4 weeks, subsequently followed by a double-blind placebo-controlled (DBPC) challenge. Out of these patients, 276 patients (30%) were suffering from a wheat sensitivity, as they were identified as being asymptomatic on an elimination diet, followed by symptoms during the DBPC challenge.</p><p>The same group evaluated the same cohort of patients in a prospective study [<xref rid="B16-nutrients-10-01727" ref-type="bibr">16</xref>], with a median follow up of 99 months in 200 patients. A total of 148 patients (74%) were still following a wheat free diet at follow up, and 127 patients (64%) were on a strict gluten-free diet. A total of 22 of these patients were randomised to the DBPC wheat re-challenge. A total of 20 of the 22 patients (91%) still reacted to wheat. This suggests that even in the long term, a subgroup of patients with IBS is likely to have a persistent sensitivity to wheat.</p><p>Confocal endomicroscopy has shown immediate and dramatic mucosal responses to wheat as an antigen [<xref rid="B17-nutrients-10-01727" ref-type="bibr">17</xref>]. Another study with 80 participants who reported symptoms related to wheat, demonstrated systemic immune activation and compromised intestinal epithelial barrier integrity in these individuals [<xref rid="B18-nutrients-10-01727" ref-type="bibr">18</xref>]. This may provide a morphological basis for wheat causing symptoms in individuals with IBS. There is currently little data known on the long-term risks of a wheat free diet in patients with IBS, with studies required to assess this.</p></sec><sec id="sec3-nutrients-10-01727"><title>3. Gluten-Free Diet</title><p>Many individuals note symptoms following the ingestion of gluten. This has led to the term of non-coeliac gluten sensitivity (NCGS), being described as early as the 1980s [<xref rid="B19-nutrients-10-01727" ref-type="bibr">19</xref>]. The mechanism of induction of symptoms in individuals is unclear, but it has been suggested that gluten proteins may be insufficiently degraded by gut proteases, which could lead to an innate immune response [<xref rid="B20-nutrients-10-01727" ref-type="bibr">20</xref>]. However, further research is required to elucidate the mechanism.</p><p>Gluten has been demonstrated to generate symptoms in individuals with IBS [<xref rid="B21-nutrients-10-01727" ref-type="bibr">21</xref>]. A DBPC trial in 34 patients with a diagnosis of IBS who had improved on a GFD were given either gluten or placebo in the form of two bread slices plus one muffin per day, with a GFD for up to 6-weeks. The study demonstrated worsening symptoms on the visual analogue scale (VAS) for overall symptoms (<italic>p</italic> = 0.047), pain (<italic>p</italic> = 0.016), bloating (<italic>p</italic> = 0.016), stool consistency (<italic>p</italic> = 0.024), and tiredness (<italic>p</italic> = 0.001) with gluten. The same group later performed a study demonstrating no effects of gluten in patients with NCGS and IBS [<xref rid="B22-nutrients-10-01727" ref-type="bibr">22</xref>], in contrast to their previous study. This double-blind crossover trial in 37 subjects with NCGS and IBS involved placing participants on a 2-week diet of reduced FODMAPs, followed by the random allocation to high-gluten (16 g gluten/day), low-gluten (2 g gluten/day and 14 g whey protein/day), or control (16 g whey protein/day) diets for 1 week, followed by a washout period of at least 2 weeks. The authors concluded that there were no dose-dependent effects of gluten on patients placed on a low FODMAP diet. However, the findings of this study may be explained by the study design and participants. As participants knew they were going to receive either high-gluten, low-gluten, or control, there may have been an anticipatory nocebo response which may have accounted for these findings. Secondly, participants at baseline had a high VAS, which may not be truly representative of this group.</p><p>There have also been other double-blind placebo-controlled trials evaluating the effect of gluten on IBS. A study in 148 patients with IBS involved commencing individuals on a GFD, followed by packages containing powdered gluten or gluten-free powder [<xref rid="B23-nutrients-10-01727" ref-type="bibr">23</xref>]. Symptomatic improvement was different in the gluten-containing group in comparison to the placebo group, with symptoms being controlled in 25.7% in the gluten-containing group, compared to 83.8% in the placebo group. Another DBPC trial in India [<xref rid="B24-nutrients-10-01727" ref-type="bibr">24</xref>] showed similar findings. A total of 60 patients with IBS completed this study, in which participants underwent a GFD for 4 weeks, followed by a re-challenge of placebo (gluten-free breads) or gluten (whole cereal breads). The study demonstrated that participants in the gluten intervention group scored higher in terms of abdominal pain, bloating, and tiredness (<italic>p</italic> &#x0003c; 0.05).</p><p>Randomised controlled trials (RCT) have demonstrated the benefit of a GFD. An RCT [<xref rid="B25-nutrients-10-01727" ref-type="bibr">25</xref>] in 45 patients with IBS-D, in which participants were allocated to either a 4 week trial of a GFD or gluten-containing diet, demonstrated an increase in bowel movements per day in those on a gluten-containing diet (<italic>p</italic> = 0.04). Interestingly, individuals taking a gluten-containing diet were noted to be associated with a higher small bowel permeability, with small bowel permeability greater in HLA DQ2/8 positive than negative patients (<italic>p</italic> = 0.018). A GFD was noted to have a greater effect of bowel movements per day in HLA DQ2/8 positive than negative patients (<italic>p</italic> = 0.019). It is, therefore, possible that gluten affects the bowel barrier function on IBS, with HLA DQ2/8 being a susceptible factor. A prospective study [<xref rid="B26-nutrients-10-01727" ref-type="bibr">26</xref>] in 41 patients also demonstrated a clinical response (reduction in IBS-Symptom Severity Score from 286 to 131, <italic>p</italic> &#x0003c; 0.001) in individuals with IBS-D placed on a 6 week GFD. Interestingly, from this study, 21 out of the 29 individuals (72%) in the study planned to continue this diet in the long term, with individuals noted to still be on the diet at a mean of 18 months.</p><p>The majority of patients taking a GFD in IBS appear to be adherent to the diet. A study [<xref rid="B27-nutrients-10-01727" ref-type="bibr">27</xref>] in 35 patients with IBS noted that in those individuals who responded to a GFD, 64% (7 out of 11 patients) were still adherent. This data are similar to patients with coeliac disease, where full adherence has been reported at 65 percent and partial adherence at 31 percent [<xref rid="B28-nutrients-10-01727" ref-type="bibr">28</xref>]. This may suggest the ease of implementation of a GFD in IBS. Additionally, the GFD is an exclusion diet, which is defined as the exclusion of one or two foods from the diet, in comparison to an elimination diet, which involves the removal of a selection of foods [<xref rid="B29-nutrients-10-01727" ref-type="bibr">29</xref>]. This may help with ease of implementation of the GFD in comparison to elimination diets, such as the low FODMAP diet. However, there have been no direct comparisons in the literature between the low FODMAP diet and GFD with regards to ease of implementation.</p><p>Individuals who maintain a GFD have the option of purchasing specialised gluten-free products. For individuals with coeliac disease consuming a GFD, it has been demonstrated that the majority of individuals purchase gluten-free products [<xref rid="B30-nutrients-10-01727" ref-type="bibr">30</xref>]. A study in the UK demonstrated that gluten-free foods were 4 times more expensive than non-gluten-free alternatives (<italic>p</italic> &#x0003c; 0.0001), with regular and quality supermarkets stocking a median of 22 items, in comparison to nil in budget supermarkets [<xref rid="B31-nutrients-10-01727" ref-type="bibr">31</xref>]. This may suggest that cost may limit the purchase of specialised gluten-products, especially for individuals from lower socioeconomic classes. However, it is important to note that alternatively there are naturally occurring foods free of gluten, which do not require the purchase of specialist products to maintain a GFD. Therefore, it is uncertain whether a GFD is more expensive to implement than a standard diet, and there is no literature to date on this in patients with IBS.</p><p>Recently a combination of the low FODMAP diet and GFD (LF-GFD) demonstrated benefit in patients with coeliac disease and co-existing functional symptoms [<xref rid="B32-nutrients-10-01727" ref-type="bibr">32</xref>]. This randomised double-blind study recruited patients with coeliac disease on a GFD for at least one year, with a negative plasma tissue transglutaminase (TTG) value with IBS symptoms fulfilling the Rome III criteria. A total of 50 participants were randomly allocated to an LF-GFD or GFD only. Participants received a structured dietary plan from a nutritionist for a 21-day period. A significant reduction in the VAS for abdominal pain was noted in the LF-GFD group versus the regular GFD group (<italic>p</italic> &#x0003c; 0.01). The general well-being increased in both groups, although a higher improvement was noted in the LF-GFD combination group (<italic>p</italic> = 0.03) [<xref rid="B32-nutrients-10-01727" ref-type="bibr">32</xref>]. Further studies are required to assess whether this could be an effective therapy for individuals with coeliac disease and IBS, as well as long-term studies being required.</p></sec><sec id="sec4-nutrients-10-01727"><title>4. Unanswered Questions</title><p>Despite the growing evidence for a GFD, a number of questions remain. Little is known about the potential effect of nutritional deficiencies in patients with IBS undergoing a GFD, with data being extrapolated from individuals on a GFD as a result of coeliac disease. A prospective validated 5-day food diary [<xref rid="B33-nutrients-10-01727" ref-type="bibr">33</xref>], in which 139 patients with coeliac disease were invited to fill, demonstrated similar intake of nutrients and energy to comparator populations, but a higher proportion of carbohydrate intake was obtained from non-milk extrinsic sugars and intakes of non-starch polysaccharides were low. Another study in 47 individuals with coeliac disease on a GFD, estimated three-day food records. Lower than recommended intakes of fibre and calcium in men and women was noted [<xref rid="B34-nutrients-10-01727" ref-type="bibr">34</xref>]. A GFD has been demonstrated to be poor in alimentary fibre, as well as micronutrient deficiencies being noted [<xref rid="B35-nutrients-10-01727" ref-type="bibr">35</xref>]. Whilst macronutrient and micronutrient deficiencies have been demonstrated on a GFD, these may not necessarily be a result of the GFD itself. It may be that the changes seen are reflective of overall community dietary habits and pre-existing individual eating habits, rather than the GFD alone [<xref rid="B36-nutrients-10-01727" ref-type="bibr">36</xref>,<xref rid="B37-nutrients-10-01727" ref-type="bibr">37</xref>]. For example, a cross-sectional population-based study in the UK [<xref rid="B38-nutrients-10-01727" ref-type="bibr">38</xref>] demonstrated that over 95% of men and women were not adherent to fibre recommendations. A significant reduction in energy intake has also been demonstrated in individuals following traditional dietary advice [<xref rid="B39-nutrients-10-01727" ref-type="bibr">39</xref>]. Additionally, it is unknown whether individuals with IBS will have the same macro- and micro-nutrient deficiencies as individuals on a GFD for coeliac disease, and this may differ on the level of gluten restriction implemented by individuals.</p><p>As can be seen, macro- and micronutrient deficiencies can occur with any diet, and this highlights the importance of dietetic involvement in the implementation of dietary therapies and is supported by other reviews [<xref rid="B40-nutrients-10-01727" ref-type="bibr">40</xref>,<xref rid="B41-nutrients-10-01727" ref-type="bibr">41</xref>]. It has been shown that whilst the vast majority of physicians gave patients advice about the improvement of diet or dietary habit for IBS [<xref rid="B42-nutrients-10-01727" ref-type="bibr">42</xref>], only a minority would recommend referral to a specialist dietitian [<xref rid="B43-nutrients-10-01727" ref-type="bibr">43</xref>]. The GFD for IBS should be implemented by a dietitian with a specialist interest in IBS, with physicians referring to dietitians for assessment. This is on the basis that the evidence base for dietary therapies for IBS has been derived from dietitian-led studies rather than physician-led dietary advice [<xref rid="B41-nutrients-10-01727" ref-type="bibr">41</xref>]. Whilst a GFD diet may be beneficial for some individuals with IBS, it is important that the most appropriate dietary therapy is identified by a dietitian through a detailed history involving the patient. This is important as there is evidence also for the use of a low FODMAP diet and WFD [<xref rid="B44-nutrients-10-01727" ref-type="bibr">44</xref>], with the NICE [<xref rid="B45-nutrients-10-01727" ref-type="bibr">45</xref>] and BDA [<xref rid="B46-nutrients-10-01727" ref-type="bibr">46</xref>] guidelines being recommended as first-line dietary therapies for IBS currently. The implementation of dietary therapies can also lead to the development of obsessive behaviours and orthorexia nervosa [<xref rid="B47-nutrients-10-01727" ref-type="bibr">47</xref>], highlighting the need for dietetic input to prevent this. Whilst a dietitian-led approach is advised, this is likely to lead to a strain on existing resources though, with the need for novel methods to increase efficiency if able. In IBS patients undergoing a low FODMAP diet (<italic>n</italic> = 364), dietitian-led group education has been demonstrated to be clinically effective [<xref rid="B48-nutrients-10-01727" ref-type="bibr">48</xref>], and this method could potentially be a cost-effective way to implement a GFD to patients with IBS. It is important to note, however, that there is little data evaluating group therapies versus one-to-one for a GFD in IBS to date.</p><p>Studies have explored the effect of the gut microbiota in individuals on a GFD in healthy individuals, as well as in individuals with coeliac disease [<xref rid="B49-nutrients-10-01727" ref-type="bibr">49</xref>,<xref rid="B50-nutrients-10-01727" ref-type="bibr">50</xref>,<xref rid="B51-nutrients-10-01727" ref-type="bibr">51</xref>,<xref rid="B52-nutrients-10-01727" ref-type="bibr">52</xref>]. A study in ten healthy individuals [<xref rid="B52-nutrients-10-01727" ref-type="bibr">52</xref>] using faecal samples assessed the effect of a GFD over 4 weeks on gut composition and microbiota. Bacterial populations regarded to be beneficial for health such as Bifidobacterium proportions were shown to decrease after the consumption of a GFD, raising potential concerns of a GFD. Additionally, Faecalibacterium prausnitzii proportions were shown to decrease after the consumption of a GFD in this study, with these bacteria known to be an important butyrate-producer in the colon, with butyrate being known as a key modulator of colonic health [<xref rid="B53-nutrients-10-01727" ref-type="bibr">53</xref>]. It has also been suggested that taxon-specific shifts as a result of the GFD may explain the benefits of a GFD seen in patients with IBS. A study [<xref rid="B49-nutrients-10-01727" ref-type="bibr">49</xref>] in 21 healthy individuals consuming a GFD over 4 weeks demonstrated stable inter-individual variation in the gut microbiota, with a shift of taxon-specific differences, most marked with Veillonellaceae. Veillonellaceae is considered to be a pro-inflammatory family of bacteria, and a decrease in its abundance on the GFD could be one of the mediators of the benefit observed in patients with IBS on a GFD. The GFD appears to affect species particularly involved in starch and carbohydrate metabolisms [<xref rid="B49-nutrients-10-01727" ref-type="bibr">49</xref>]. It is unclear whether this would occur in a population of IBS patients and, therefore, studies are required to assess this. Assessment of the effect of a GFD on the gut microbiota in both the short and long term is required in patients with IBS. Currently, the role of the GFD on the gut microbiota is unclear. The changes seen could be due to a GFD, or they could be due to other dietary alterations made whilst on a GFD. In the studies mentioned above [<xref rid="B49-nutrients-10-01727" ref-type="bibr">49</xref>,<xref rid="B52-nutrients-10-01727" ref-type="bibr">52</xref>], faecal flora was analysed. The faecal flora is highly organised and spatially organised [<xref rid="B54-nutrients-10-01727" ref-type="bibr">54</xref>], leading to an uneven distribution in stool samples [<xref rid="B55-nutrients-10-01727" ref-type="bibr">55</xref>], which suggests that faecal samples are unlikely to be truly representative of the gut microbiota. Sample sizes used in the studies have been small and individuals tend to be unique in terms of their gut microbiota [<xref rid="B55-nutrients-10-01727" ref-type="bibr">55</xref>]. It is also important to note that these studies focussed on the gut bacteriome, rather than the virome and mycobiome and, therefore, may not be truly representative of the entire microbiota. Further studies are required to explore the effect of the GFD on the microbiome, with the assessment of both short-term and long-term changes.</p><p>A recent systematic review and meta-analysis assessing the efficacy of a GFD in IBS [<xref rid="B40-nutrients-10-01727" ref-type="bibr">40</xref>] concluded that there was insufficient evidence to recommend a GFD to reduce IBS symptoms. Participants in the two studies [<xref rid="B21-nutrients-10-01727" ref-type="bibr">21</xref>,<xref rid="B23-nutrients-10-01727" ref-type="bibr">23</xref>] included in the review were intolerant of gluten in addition to IBS, which may suggest that these studies were not fully representative of the entire IBS population. As only two RCTs were deemed suitable for review, this led to a small sample size (<italic>n</italic> = 111), giving insufficient evidence for the reviewers to recommend this diet. However, as seen in <xref rid="nutrients-10-01727-t001" ref-type="table">Table 1</xref>, there have been a number of studies in addition to these assessing the role of the GFD in IBS [<xref rid="B21-nutrients-10-01727" ref-type="bibr">21</xref>,<xref rid="B23-nutrients-10-01727" ref-type="bibr">23</xref>,<xref rid="B24-nutrients-10-01727" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-10-01727" ref-type="bibr">25</xref>,<xref rid="B26-nutrients-10-01727" ref-type="bibr">26</xref>,<xref rid="B27-nutrients-10-01727" ref-type="bibr">27</xref>,<xref rid="B56-nutrients-10-01727" ref-type="bibr">56</xref>,<xref rid="B57-nutrients-10-01727" ref-type="bibr">57</xref>,<xref rid="B58-nutrients-10-01727" ref-type="bibr">58</xref>]. It would be difficult to include all these studies in a meta-analysis as it would be difficult to combine the data from all these studies due to the heterogeneity of these studies. Studies assessing the GFD in IBS have used different methods of delivering a GFD, such as using feeding studies in some trials and dietary advice in others. In feeding studies, different doses of gluten have also been used. Different primary outcomes have been assessed, different population groups have been enrolled, as well as different study durations. As can be seen in <xref rid="nutrients-10-01727-t001" ref-type="table">Table 1</xref>, the studies have been performed in a wide variety of geographic locations which may lead to divergent results as different geographic locations may employ the GFD differently, which also may potentially have an impact on their resident gut microbiota [<xref rid="B55-nutrients-10-01727" ref-type="bibr">55</xref>]. The design of these studies is important as this may result in different outcomes. For example, the studies by Biesiekierski and colleagues [<xref rid="B21-nutrients-10-01727" ref-type="bibr">21</xref>,<xref rid="B22-nutrients-10-01727" ref-type="bibr">22</xref>], assessing the role of a GFD in IBS, led to different outcomes as mentioned earlier, which could be attributed to study design.</p><p>Studies have focussed on patient symptoms to determine response using validated questionnaires such as the IBS-SSS [<xref rid="B59-nutrients-10-01727" ref-type="bibr">59</xref>], rather than objective biomarkers. Currently, the evidence does not suggest one biomarker in IBS, but rather a panel of biomarkers [<xref rid="B60-nutrients-10-01727" ref-type="bibr">60</xref>]. Currently, even using a panel of biomarkers has a poor sensitivity and specificity and, therefore, has limited the use of biomarkers to assess response to dietary therapies in IBS [<xref rid="B60-nutrients-10-01727" ref-type="bibr">60</xref>,<xref rid="B61-nutrients-10-01727" ref-type="bibr">61</xref>]. Therefore, further research is required in this area before objective biomarkers can be used to assess response to therapies in IBS. It appears from <xref rid="nutrients-10-01727-t001" ref-type="table">Table 1</xref> that there are several individual trials demonstrating the benefit of a GFD in IBS, demonstrating the growing evidence base for its use in IBS.</p><p>There have been a relatively smaller number of patients recruited to studies assessing the GFD in IBS. This is likely to be an issue for dietary studies in general, with a lack of pharmaceutical support for dietary therapy trials in comparison to pharmaceutical trials, as well as IBS not being a priority area for research [<xref rid="B40-nutrients-10-01727" ref-type="bibr">40</xref>]. Significant challenges remain, with a lack of guidelines for dietary trials, unlike drug trials which are closely regulated [<xref rid="B62-nutrients-10-01727" ref-type="bibr">62</xref>]. Issues also remain with regards to blinding, for example, as the GFD is well known to the general public, with up to 5 percent of individuals taking a GFD on their own volition [<xref rid="B63-nutrients-10-01727" ref-type="bibr">63</xref>,<xref rid="B64-nutrients-10-01727" ref-type="bibr">64</xref>]. In addition, other challenges remain in designing dietary trials, including difficulties in manipulating the diet and the adherence and modification of dietary habits. It is also difficult to practically implement the findings from dietary trials to the real world [<xref rid="B65-nutrients-10-01727" ref-type="bibr">65</xref>].</p><p>It is unclear which component of wheat leads to symptom generation. Several components have been suggested as the causal agent, including gluten, alpha-amylase trypsin inhibitors (ATIs), wheat germ agglutinins (WGAs), and fructans, which are part of the low FODMAP diet [<xref rid="B66-nutrients-10-01727" ref-type="bibr">66</xref>]. Studies have been performed to try to elucidate the pathophysiological mechanisms of these components in symptom generation. Gluten has been demonstrated to alter bowel barrier functions in patients with IBS. The expression of tight junction proteins (ZO-1, occludin, and claudin-1) have been demonstrated to be significantly lower in the colonic mucosa of individuals on a gluten-containing diet, especially in individuals who are HLA DQ2/ 8 positive [<xref rid="B25-nutrients-10-01727" ref-type="bibr">25</xref>]. Tight junction proteins, claudin-2, 8 and 15, as well as myosin light chain kinase (MLCK)-myosin II regulatory light chain (MLC) pathway have been demonstrated to be important in intestinal physiology and barrier function, regulating paracellular permeability. A study [<xref rid="B67-nutrients-10-01727" ref-type="bibr">67</xref>] evaluating biopsies from 27 patients with IBS-D demonstrated alterations in MLC phosphorylation and claudin-15 and claudin-2 expression with gluten with intestinal permeability changes. This also could potentially explain permeability responses to gluten challenge in patients with IBS [<xref rid="B67-nutrients-10-01727" ref-type="bibr">67</xref>]. ATIs have been demonstrated to be strong induces of the innate immune responses, in vitro and in vivo, via the activation of the toll-like receptor 4, with the release of pro-inflammatory cytokines leading to intestinal inflammation [<xref rid="B68-nutrients-10-01727" ref-type="bibr">68</xref>]. WGA is the best-studied cereal grain lectin. When delivered in vitro, WGAs have been demonstrated to stimulate monocytes and macrophages, which have the ability to initiate and maintain inflammatory responses [<xref rid="B69-nutrients-10-01727" ref-type="bibr">69</xref>]. WGA has been demonstrated to affect enterocyte permeability in vitro. However, it is important to note that human data demonstrating WGA on inflammatory markers are lacking [<xref rid="B69-nutrients-10-01727" ref-type="bibr">69</xref>]. FODMAPs are short-chain carbohydrates which are rapidly fermentable and poorly absorbed, increasing the small bowel water content, passing unaltered into the colon, where they are rapidly fermented, generating gas and distention [<xref rid="B70-nutrients-10-01727" ref-type="bibr">70</xref>]. Similar physiological responses to FODMAPs has been demonstrated in both healthy individuals and patients with IBS, indicating that colonic hypersensitivity to distention in patients with IBS is likely to be the pathophysiological mechanism [<xref rid="B71-nutrients-10-01727" ref-type="bibr">71</xref>]. FODMAPs are considered to be beneficial to epithelial cell integrity and health [<xref rid="B72-nutrients-10-01727" ref-type="bibr">72</xref>].</p><p>A recent study has suggested that fructans rather than gluten are responsible for symptoms seen in patients with IBS. The study [<xref rid="B73-nutrients-10-01727" ref-type="bibr">73</xref>] in 59 individuals who had already self-instituted a GFD involved a double-blind crossover challenge, in which individuals were randomly assigned to diets containing fructans, placebo, and gluten for 7 days, followed by a minimum 7 day washout period. The overall gastrointestinal symptom rating scale (GSRS) score for participants consuming fructans was significantly higher than those consuming gluten (<italic>p</italic> = 0.049).</p><p>It is likely that there is a significant overlap between dietary therapies used in IBS including the GFD, WFD, and low FODMAP diet. They are likely to be &#x02018;dietary cousins&#x02019;, with each diet being needed to be tailored to the individual patient after a detailed assessment by a dietitian. There appears to be a spectrum of gluten-related disorders, as seen in <xref ref-type="fig" rid="nutrients-10-01727-f001">Figure 1</xref>.</p><p>It is important to note that there are several other dietary therapies which are being explored in patients with IBS. As the evidence is growing for gluten in generating symptoms in IBS, it is possible to hypothesise that other foods may also contain harmful molecules for patients with IBS. Some dietary therapies have focussed on diets with a primary focus on bioactive food molecules, such as the low capsaicin diet, low amine/histamine diet, and low food chemical diet [<xref rid="B47-nutrients-10-01727" ref-type="bibr">47</xref>]. Additionally, there are diets in addition to the low FODMAP diet focussing on the carbohydrates like the specific carbohydrate diet and paleo diet. Likewise, there are diets in addition to the GFD focussing on proteins, such as reduced resistant protein diet. However, to date, there is little evidence for the use of these diets in patients with IBS [<xref rid="B47-nutrients-10-01727" ref-type="bibr">47</xref>].</p></sec><sec id="sec5-nutrients-10-01727"><title>5. Conclusions</title><p>There appears to be emerging evidence for the use of a GFD in IBS. A number of unanswered questions remain, including the effect on the gut microbiota in both the short and long term, as well as the effect on short- and long-term nutritional adequacy. This dietary therapy should be implemented by a dietitian with a specialist interest in IBS, which could be done through group clinics, although research is required to validate this. There is likely to be an overlap with other dietary therapies such as the low FODMAP diet, with which component of wheat leading to the induction of symptoms still being unclear. Further research is required on the use of a GFD in IBS, but dietary studies are likely to be challenging, with blinding and funding being some of the issues.</p></sec></body><back><notes><title>Author Contributions</title><p>A.R. and D.S.S. wrote the initial manuscript and D.S.S. approved the final version.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-10-01727"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmulson</surname><given-names>M.J.</given-names></name><name><surname>Drossman</surname><given-names>D.A.</given-names></name></person-group><article-title>What Is New in Rome IV</article-title><source>J. Neurogastroenterol. Motil.</source><year>2017</year><volume>23</volume><fpage>151</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.5056/jnm16214</pub-id><?supplied-pmid 28274109?><pub-id pub-id-type="pmid">28274109</pub-id></element-citation></ref><ref id="B2-nutrients-10-01727"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovell</surname><given-names>R.M.</given-names></name><name><surname>Ford</surname><given-names>A.C.</given-names></name></person-group><article-title>Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2012</year><volume>10</volume><fpage>712</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2012.02.029</pub-id><?supplied-pmid 22426087?><pub-id pub-id-type="pmid">22426087</pub-id></element-citation></ref><ref id="B3-nutrients-10-01727"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camilleri</surname><given-names>M.</given-names></name><name><surname>Lasch</surname><given-names>K.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name></person-group><article-title>Irritable bowel syndrome: Methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome</article-title><source>AJP: Gastrointest. Liver Physiol.</source><year>2012</year><volume>303</volume><fpage>G775</fpage><lpage>G785</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00155.2012</pub-id><?supplied-pmid 22837345?><pub-id pub-id-type="pmid">22837345</pub-id></element-citation></ref><ref id="B4-nutrients-10-01727"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portincasa</surname><given-names>P.</given-names></name><name><surname>Bonfrate</surname><given-names>L.</given-names></name><name><surname>De Bari</surname><given-names>O.</given-names></name><name><surname>Lembo</surname><given-names>A.</given-names></name><name><surname>Ballou</surname><given-names>S.</given-names></name></person-group><article-title>Irritable bowel syndrome and diet</article-title><source>Gastroenterol. Rep. (Oxf)</source><year>2017</year><volume>5</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1093/gastro/gow047</pub-id><?supplied-pmid 28110300?><pub-id pub-id-type="pmid">28110300</pub-id></element-citation></ref><ref id="B5-nutrients-10-01727"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akehurst</surname><given-names>R.L.</given-names></name><name><surname>Brazier</surname><given-names>J.E.</given-names></name><name><surname>Mathers</surname><given-names>N.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>C.</given-names></name><name><surname>Kaltenthaler</surname><given-names>E.</given-names></name><name><surname>Morgan</surname><given-names>A.</given-names></name><name><surname>Platts</surname><given-names>M.</given-names></name><name><surname>Walters</surname><given-names>S.J.</given-names></name></person-group><article-title>Health-related quality of life and cost impact of irritable bowel syndrome in a uk primary care setting</article-title><source>Pharm. Economics.</source><year>2002</year><volume>20</volume><fpage>455</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.2165/00019053-200220070-00003</pub-id><?supplied-pmid 12093301?><pub-id pub-id-type="pmid">12093301</pub-id></element-citation></ref><ref id="B6-nutrients-10-01727"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehead</surname><given-names>W.E.</given-names></name><name><surname>Palsson</surname><given-names>O.</given-names></name><name><surname>Jones</surname><given-names>K.R.</given-names></name></person-group><article-title>Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?</article-title><source>Gastroenterology</source><year>2002</year><volume>122</volume><fpage>1140</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1053/gast.2002.32392</pub-id><?supplied-pmid 11910364?><pub-id pub-id-type="pmid">11910364</pub-id></element-citation></ref><ref id="B7-nutrients-10-01727"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahner</surname><given-names>E.</given-names></name><name><surname>Bellentani</surname><given-names>S.</given-names></name><name><surname>Bastiani</surname><given-names>R.D.</given-names></name><name><surname>Tosetti</surname><given-names>C.</given-names></name><name><surname>Cicala</surname><given-names>M.</given-names></name><name><surname>Esposito</surname><given-names>G.</given-names></name><name><surname>Arullani</surname><given-names>P.</given-names></name><name><surname>Annibale</surname><given-names>B.</given-names></name></person-group><article-title>A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders</article-title><source>States Eur. Gastroenterol. J.</source><year>2013</year><volume>1</volume><fpage>385</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1177/2050640613499567</pub-id><?supplied-pmid 24917987?><pub-id pub-id-type="pmid">24917987</pub-id></element-citation></ref><ref id="B8-nutrients-10-01727"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simr&#x000e9;n</surname><given-names>M.</given-names></name><name><surname>M&#x000e5;nsson</surname><given-names>A.</given-names></name><name><surname>Langkilde</surname><given-names>A.M.</given-names></name><name><surname>Svedlund</surname><given-names>J.</given-names></name><name><surname>Abrahamsson</surname><given-names>H.</given-names></name><name><surname>Bengtsson</surname><given-names>U.</given-names></name><name><surname>Bj&#x000f6;rnsson</surname><given-names>E.S.</given-names></name></person-group><article-title>Food-related gastrointestinal symptoms in the irritable bowel syndrome</article-title><source>Digestion</source><year>2001</year><volume>63</volume><fpage>108</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1159/000051878</pub-id><?supplied-pmid 11244249?><pub-id pub-id-type="pmid">11244249</pub-id></element-citation></ref><ref id="B9-nutrients-10-01727"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monsbakken</surname><given-names>K.W.</given-names></name><name><surname>Vandvik</surname><given-names>P.O.</given-names></name><name><surname>Farup</surname><given-names>P.G.</given-names></name></person-group><article-title>Perceived food intolerance in subjects with irritable bowel syndrome&#x02014;etiology, prevalence and consequences</article-title><source>Eur. J. Clin. Nutr.</source><year>2005</year><volume>60</volume><fpage>667</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602367</pub-id><?supplied-pmid 16391571?><pub-id pub-id-type="pmid">16391571</pub-id></element-citation></ref><ref id="B10-nutrients-10-01727"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;hn</surname><given-names>L.</given-names></name><name><surname>St&#x000f6;rsrud</surname><given-names>S.</given-names></name><name><surname>Simr&#x000e9;n</surname><given-names>M.</given-names></name></person-group><article-title>Nutrient intake in patients with irritable bowel syndrome compared with the general population</article-title><source>Neurogastroenterol. Motil.</source><year>2013</year><volume>25</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1111/nmo.12001</pub-id><?supplied-pmid 22937900?><pub-id pub-id-type="pmid">22937900</pub-id></element-citation></ref><ref id="B11-nutrients-10-01727"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>I.</given-names></name><name><surname>Karajeh</surname><given-names>M.A.</given-names></name><name><surname>Zilkha</surname><given-names>J.</given-names></name><name><surname>Tubman</surname><given-names>E.</given-names></name><name><surname>Fowles</surname><given-names>C.</given-names></name><name><surname>Sanders</surname><given-names>D.S.</given-names></name></person-group><article-title>Change in awareness of gluten-related disorders among chefs and the general public in the uk</article-title><source>Eur. J. Gastroenterol. Hepatol.</source><year>2014</year><volume>26</volume><fpage>1228</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1097/MEG.0000000000000166</pub-id><?supplied-pmid 25144492?><pub-id pub-id-type="pmid">25144492</pub-id></element-citation></ref><ref id="B12-nutrients-10-01727"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niland</surname><given-names>B.</given-names></name><name><surname>Cash</surname><given-names>B.D.</given-names></name></person-group><article-title>Health Benefits and Adverse Effects of a Gluten-Free Diet in Non-Celiac Disease Patients</article-title><source>Gastroenterol. Hepatol.</source><year>2018</year><volume>14</volume><fpage>82</fpage><lpage>91</lpage></element-citation></ref><ref id="B13-nutrients-10-01727"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebwohl</surname><given-names>B.</given-names></name><name><surname>Sanders</surname><given-names>D.S.</given-names></name><name><surname>Green</surname><given-names>P.H.R.</given-names></name></person-group><article-title>Coeliac disease</article-title><source>Lancet</source><year>2018</year><volume>391</volume><fpage>70</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)31796-8</pub-id><pub-id pub-id-type="pmid">28760445</pub-id></element-citation></ref><ref id="B14-nutrients-10-01727"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golley</surname><given-names>S.</given-names></name><name><surname>Corsini</surname><given-names>N.</given-names></name><name><surname>Topping</surname><given-names>D.</given-names></name><name><surname>Morell</surname><given-names>M.</given-names></name><name><surname>Mohr</surname><given-names>P.</given-names></name></person-group><article-title>Motivations for avoiding wheat consumption in australia: Results from a population survey</article-title><source>Public Heal. Nutr.</source><year>2014</year><volume>18</volume><fpage>490</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1017/S1368980014000652</pub-id><?supplied-pmid 24739252?><pub-id pub-id-type="pmid">24739252</pub-id></element-citation></ref><ref id="B15-nutrients-10-01727"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroccio</surname><given-names>A.</given-names></name><name><surname>Mansueto</surname><given-names>P.</given-names></name><name><surname>Iacono</surname><given-names>G.</given-names></name><name><surname>Soresi</surname><given-names>M.</given-names></name><name><surname>D&#x02019;Alcamo</surname><given-names>A.</given-names></name><name><surname>Cavataio</surname><given-names>F.</given-names></name><name><surname>Brusca</surname><given-names>I.</given-names></name><name><surname>Florena</surname><given-names>A.M.</given-names></name><name><surname>Ambrosiano</surname><given-names>G.</given-names></name><name><surname>Seidita</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: Exploring a new clinical entity</article-title><source>Am. J. Gastroenterol</source><year>2012</year><volume>107</volume><fpage>1898</fpage><lpage>1906</lpage><pub-id pub-id-type="doi">10.1038/ajg.2012.236</pub-id><?supplied-pmid 22825366?><pub-id pub-id-type="pmid">22825366</pub-id></element-citation></ref><ref id="B16-nutrients-10-01727"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroccio</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Alcamo</surname><given-names>A.</given-names></name><name><surname>Iacono</surname><given-names>G.</given-names></name><name><surname>Soresi</surname><given-names>M.</given-names></name><name><surname>Iacobucci</surname><given-names>R.</given-names></name><name><surname>Arini</surname><given-names>A.</given-names></name><name><surname>Geraci</surname><given-names>G.</given-names></name><name><surname>Cavataio</surname><given-names>F.</given-names></name><name><surname>La Biasca</surname><given-names>F.</given-names></name><name><surname>Florena</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>Persistence of Nonceliac Wheat Sensitivity, Based on Long-term Follow-up</article-title><source>Gastroenterology</source><year>2017</year><volume>153</volume><fpage>56</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2017.03.034</pub-id><?supplied-pmid 28365444?><pub-id pub-id-type="pmid">28365444</pub-id></element-citation></ref><ref id="B17-nutrients-10-01727"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritscher-Ravens</surname><given-names>A.</given-names></name><name><surname>Schuppan</surname><given-names>D.</given-names></name><name><surname>Ellrichmann</surname><given-names>M.</given-names></name><name><surname>Schoch</surname><given-names>S.</given-names></name><name><surname>R&#x000f6;cken</surname><given-names>C.</given-names></name><name><surname>Brasch</surname><given-names>J.</given-names></name><name><surname>Bethge</surname><given-names>J.</given-names></name><name><surname>B&#x000f6;ttner</surname><given-names>M.</given-names></name><name><surname>Klose</surname><given-names>J.</given-names></name><name><surname>Milla</surname><given-names>P.J.</given-names></name></person-group><article-title>Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome</article-title><source>Gastroenterology</source><year>2014</year><volume>147</volume><fpage>1012</fpage><lpage>1020</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2014.07.046</pub-id><?supplied-pmid 25083606?><pub-id pub-id-type="pmid">25083606</pub-id></element-citation></ref><ref id="B18-nutrients-10-01727"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhde</surname><given-names>M.</given-names></name><name><surname>Ajamian</surname><given-names>M.</given-names></name><name><surname>Caio</surname><given-names>G.</given-names></name><name><surname>De Giorgio</surname><given-names>R.</given-names></name><name><surname>Indart</surname><given-names>A.</given-names></name><name><surname>Green</surname><given-names>P.H.</given-names></name><name><surname>Verna</surname><given-names>E.C.</given-names></name><name><surname>Volta</surname><given-names>U.</given-names></name><name><surname>Alaedini</surname><given-names>A.</given-names></name></person-group><article-title>Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease</article-title><source>Gut</source><year>2016</year><volume>65</volume><fpage>1930</fpage><lpage>1937</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2016-311964</pub-id><?supplied-pmid 27459152?><pub-id pub-id-type="pmid">27459152</pub-id></element-citation></ref><ref id="B19-nutrients-10-01727"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>B.T.</given-names></name><name><surname>Holmes</surname><given-names>G.K.</given-names></name><name><surname>Ferguson</surname><given-names>R.</given-names></name><name><surname>Thompson</surname><given-names>R.A.</given-names></name><name><surname>Allan</surname><given-names>R.N.</given-names></name><name><surname>Cooke</surname><given-names>W.T.</given-names></name></person-group><article-title>Gluten-sensitive diarrhea without evidence of celiac disease</article-title><source>Gastroenterology</source><year>1980</year><volume>79</volume><fpage>801</fpage><lpage>806</lpage><?supplied-pmid 7419003?><pub-id pub-id-type="pmid">7419003</pub-id></element-citation></ref><ref id="B20-nutrients-10-01727"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volta</surname><given-names>U.</given-names></name><name><surname>Pinto-Sanchez</surname><given-names>M.I.</given-names></name><name><surname>Boschetti</surname><given-names>E.</given-names></name><name><surname>Caio</surname><given-names>G.</given-names></name><name><surname>De Giorgio</surname><given-names>R.</given-names></name><name><surname>Verdu</surname><given-names>E.F.</given-names></name></person-group><article-title>Dietary Triggers in Irritable Bowel Syndrome: Is There a Role for Gluten?</article-title><source>J. Neurogastroenterol. Motil.</source><year>2016</year><volume>22</volume><fpage>547</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.5056/jnm16069</pub-id><?supplied-pmid 27426486?><pub-id pub-id-type="pmid">27426486</pub-id></element-citation></ref><ref id="B21-nutrients-10-01727"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biesiekierski</surname><given-names>J.R.</given-names></name><name><surname>Newnham</surname><given-names>E.D.</given-names></name><name><surname>Irving</surname><given-names>P.M.</given-names></name><name><surname>Barrett</surname><given-names>J.S.</given-names></name><name><surname>Haines</surname><given-names>M.</given-names></name><name><surname>Doecke</surname><given-names>J.D.</given-names></name><name><surname>Shepherd</surname><given-names>S.J.</given-names></name><name><surname>Muir</surname><given-names>J.G.</given-names></name><name><surname>Gibson</surname><given-names>P.R.</given-names></name></person-group><article-title>Gluten causes gastrointestinal symptoms in subjects without celiac disease: A double-blind randomized placebo-controlled trial</article-title><source>Am. J. Gastroenterol.</source><year>2011</year><volume>106</volume><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1038/ajg.2010.487</pub-id><?supplied-pmid 21224837?><pub-id pub-id-type="pmid">21224837</pub-id></element-citation></ref><ref id="B22-nutrients-10-01727"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biesiekierski</surname><given-names>J.R.</given-names></name><name><surname>Peters</surname><given-names>S.L.</given-names></name><name><surname>Newnham</surname><given-names>E.D.</given-names></name><name><surname>Rosella</surname><given-names>O.</given-names></name><name><surname>Muir</surname><given-names>J.G.</given-names></name><name><surname>Gibson</surname><given-names>P.R.</given-names></name></person-group><article-title>No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates</article-title><source>Gastroenterology</source><year>2013</year><volume>145</volume><fpage>320</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.04.051</pub-id><?supplied-pmid 23648697?><pub-id pub-id-type="pmid">23648697</pub-id></element-citation></ref><ref id="B23-nutrients-10-01727"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahbazkhani</surname><given-names>B.</given-names></name><name><surname>Sadeghi</surname><given-names>A.</given-names></name><name><surname>Malekzadeh</surname><given-names>R.</given-names></name><name><surname>Khatavi</surname><given-names>F.</given-names></name><name><surname>Etemadi</surname><given-names>M.</given-names></name><name><surname>Kalantri</surname><given-names>E.</given-names></name><name><surname>Rostami-Nejad</surname><given-names>M.</given-names></name><name><surname>Rostami</surname><given-names>K.</given-names></name></person-group><article-title>Non-celiac gluten sensitivity has narrowed the spectrum of irritable bowel syndrome: a double-blind randomized placebo-controlled trial</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><fpage>4542</fpage><lpage>4554</lpage><pub-id pub-id-type="doi">10.3390/nu7064542</pub-id><?supplied-pmid 26056920?><pub-id pub-id-type="pmid">26056920</pub-id></element-citation></ref><ref id="B24-nutrients-10-01727"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanwar</surname><given-names>V.G.</given-names></name><name><surname>Pawar</surname><given-names>S.V.</given-names></name><name><surname>Gambhire</surname><given-names>P.A.</given-names></name><name><surname>Jain</surname><given-names>S.S.</given-names></name><name><surname>Surude</surname><given-names>R.G.</given-names></name><name><surname>Shah</surname><given-names>V.B.</given-names></name><name><surname>Contractor</surname><given-names>Q.Q.</given-names></name><name><surname>Rathi</surname><given-names>P.M.</given-names></name></person-group><article-title>Symptomatic improvement with gluten restriction in irritable bowel syndrome: A prospective, randomized, double blinded placebo controlled trial</article-title><source>Intest. Res.</source><year>2016</year><volume>14</volume><fpage>343</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.5217/ir.2016.14.4.343</pub-id><?supplied-pmid 27799885?><pub-id pub-id-type="pmid">27799885</pub-id></element-citation></ref><ref id="B25-nutrients-10-01727"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vazquez&#x02013;Roque</surname><given-names>M.I.</given-names></name><name><surname>Camilleri</surname><given-names>M.</given-names></name><name><surname>Smyrk</surname><given-names>T.</given-names></name><name><surname>Murray</surname><given-names>J.A.</given-names></name><name><surname>Marietta</surname><given-names>E.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>J.</given-names></name><name><surname>Carlson</surname><given-names>P.</given-names></name><name><surname>Lamsam</surname><given-names>J.</given-names></name><name><surname>Janzow</surname><given-names>D.</given-names></name><name><surname>Eckert</surname><given-names>D.</given-names></name><etal/></person-group><article-title>A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: Effects on bowel frequency and intestinal function</article-title><source>Gastroenterology</source><year>2013</year><volume>144</volume><fpage>903</fpage><lpage>911</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.01.049</pub-id><?supplied-pmid 23357715?><pub-id pub-id-type="pmid">23357715</pub-id></element-citation></ref><ref id="B26-nutrients-10-01727"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>I.</given-names></name><name><surname>Trott</surname><given-names>N.</given-names></name><name><surname>Briggs</surname><given-names>R.</given-names></name><name><surname>North</surname><given-names>J.R.</given-names></name><name><surname>Hadjivassiliou</surname><given-names>M.</given-names></name><name><surname>Sanders</surname><given-names>D.S.</given-names></name></person-group><article-title>Efficacy of a gluten-free diet in subjects with irritable bowel syndrome-diarrhea unaware of their hla-dq2/8 genotype</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2016</year><volume>14</volume><fpage>696</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2015.12.031</pub-id><?supplied-pmid 26748221?><pub-id pub-id-type="pmid">26748221</pub-id></element-citation></ref><ref id="B27-nutrients-10-01727"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barmeyer</surname><given-names>C.</given-names></name><name><surname>Schumann</surname><given-names>M.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>Zielinski</surname><given-names>C.</given-names></name><name><surname>Zuberbier</surname><given-names>T.</given-names></name><name><surname>Siegmund</surname><given-names>B.</given-names></name><name><surname>Schulzke</surname><given-names>J.-D.</given-names></name><name><surname>Daum</surname><given-names>S.</given-names></name><name><surname>Ullrich</surname><given-names>R.</given-names></name></person-group><article-title>Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome</article-title><source>Int. J. Color. Dis.</source><year>2016</year><volume>32</volume><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1007/s00384-016-2663-x</pub-id><?supplied-pmid 27695975?><pub-id pub-id-type="pmid">27695975</pub-id></element-citation></ref><ref id="B28-nutrients-10-01727"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barratt</surname><given-names>S.M.</given-names></name><name><surname>Leeds</surname><given-names>J.S.</given-names></name><name><surname>Sanders</surname><given-names>D.S.</given-names></name></person-group><article-title>Quality of life in Coeliac Disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved</article-title><source>J. Gastrointest. Liver Dis.</source><year>2011</year><volume>20</volume><fpage>241</fpage><lpage>245</lpage></element-citation></ref><ref id="B29-nutrients-10-01727"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>Y.A.</given-names></name><name><surname>Alder</surname><given-names>A.</given-names></name><name><surname>Anderson</surname><given-names>W.</given-names></name><name><surname>Wills</surname><given-names>A.</given-names></name><name><surname>Goddard</surname><given-names>L.</given-names></name><name><surname>Gulia</surname><given-names>P.</given-names></name><name><surname>Jankovich</surname><given-names>E.</given-names></name><name><surname>Mutch</surname><given-names>P.</given-names></name><name><surname>Reeves</surname><given-names>L.B.</given-names></name><name><surname>Singer</surname><given-names>A.</given-names></name><etal/></person-group><article-title>British dietetic association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults</article-title><source>J. Hum. Nutr. Diet.</source><year>2012</year><volume>25</volume><fpage>260</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1111/j.1365-277X.2012.01242.x</pub-id><?supplied-pmid 22489905?><pub-id pub-id-type="pmid">22489905</pub-id></element-citation></ref><ref id="B30-nutrients-10-01727"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinsey</surname><given-names>L.</given-names></name><name><surname>Burden</surname><given-names>S.T.</given-names></name><name><surname>Bannerman</surname><given-names>E.</given-names></name></person-group><article-title>A dietary survey to determine if patients with coeliac disease are meeting current healthy eating guidelines and how their diet compares to that of the british general population</article-title><source>Eur. J. Clin. Nutr.</source><year>2011</year><volume>65</volume><fpage>283</fpage><pub-id pub-id-type="doi">10.1038/ejcn.2010.256</pub-id></element-citation></ref><ref id="B31-nutrients-10-01727"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burden</surname><given-names>M.</given-names></name><name><surname>Mooney</surname><given-names>P.D.</given-names></name><name><surname>Blanshard</surname><given-names>R.J.</given-names></name><name><surname>White</surname><given-names>W.L.</given-names></name><name><surname>Cambray-Deakin</surname><given-names>D.R.</given-names></name><name><surname>Sanders</surname><given-names>D.S.</given-names></name></person-group><article-title>Cost and availability of gluten-free food in the UK: In store and online</article-title><source>Postgrad Med. J.</source><year>2015</year><volume>91</volume><fpage>622</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1136/postgradmedj-2015-133395</pub-id><?supplied-pmid 26310267?><pub-id pub-id-type="pmid">26310267</pub-id></element-citation></ref><ref id="B32-nutrients-10-01727"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roncoroni</surname><given-names>L.</given-names></name><name><surname>Bascu&#x000f1;&#x000e1;n</surname><given-names>K.A.</given-names></name><name><surname>Doneda</surname><given-names>L.</given-names></name><name><surname>Scricciolo</surname><given-names>A.</given-names></name><name><surname>Lombardo</surname><given-names>V.</given-names></name><name><surname>Branchi</surname><given-names>F.</given-names></name><name><surname>Ferretti</surname><given-names>F.</given-names></name><name><surname>Dell&#x02019;Osso</surname><given-names>B.</given-names></name><name><surname>Montanari</surname><given-names>V.</given-names></name><name><surname>Bardella</surname><given-names>M.T.</given-names></name><etal/></person-group><article-title>A Low FODMAP Gluten-Free Diet Improves Functional Gastrointestinal Disorders and Overall Mental Health of Celiac Disease Patients: A Randomized Controlled Trial</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>1023</elocation-id><pub-id pub-id-type="doi">10.3390/nu10081023</pub-id><?supplied-pmid 30081576?><pub-id pub-id-type="pmid">30081576</pub-id></element-citation></ref><ref id="B33-nutrients-10-01727"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>D.</given-names></name><name><surname>Robins</surname><given-names>G.G.</given-names></name><name><surname>Burley</surname><given-names>V.J.</given-names></name><name><surname>Howdle</surname><given-names>P.D.</given-names></name></person-group><article-title>Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet</article-title><source>Aliment. Pharmacol. Ther.</source><year>2010</year><volume>32</volume><fpage>573</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2036.2010.04386.x</pub-id><?supplied-pmid 20528829?><pub-id pub-id-type="pmid">20528829</pub-id></element-citation></ref><ref id="B34-nutrients-10-01727"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>T.</given-names></name><name><surname>Dennis</surname><given-names>M.</given-names></name><name><surname>Higgins</surname><given-names>L.A.</given-names></name><name><surname>Lee</surname><given-names>A.R.</given-names></name><name><surname>Sharrett</surname><given-names>M.K.</given-names></name></person-group><article-title>Gluten-free diet survey: Are Americans with coeliac disease consuming recommended amounts of fibre, iron, calcium and grain foods?</article-title><source>J. Hum. Nutr. Diet.</source><year>2005</year><volume>18</volume><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1111/j.1365-277X.2005.00607.x</pub-id><?supplied-pmid 15882378?><pub-id pub-id-type="pmid">15882378</pub-id></element-citation></ref><ref id="B35-nutrients-10-01727"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vici</surname><given-names>G.</given-names></name><name><surname>Belli</surname><given-names>L.</given-names></name><name><surname>Biondi</surname><given-names>M.</given-names></name><name><surname>Polzonetti</surname><given-names>V.</given-names></name></person-group><article-title>Gluten free diet and nutrient deficiencies: A review</article-title><source>Clin. Nutr.</source><year>2016</year><volume>35</volume><fpage>1236</fpage><lpage>1241</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2016.05.002</pub-id><?supplied-pmid 27211234?><pub-id pub-id-type="pmid">27211234</pub-id></element-citation></ref><ref id="B36-nutrients-10-01727"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname><given-names>S.J.</given-names></name><name><surname>Gibson</surname><given-names>P.R.</given-names></name></person-group><article-title>Nutritional inadequacies of the gluten-free diet in both recently-diagnosed and long-term patients with coeliac disease</article-title><source>J. Hum. Nutr. Diet.</source><year>2012</year><volume>26</volume><fpage>349</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1111/jhn.12018</pub-id><?supplied-pmid 23198728?><pub-id pub-id-type="pmid">23198728</pub-id></element-citation></ref><ref id="B37-nutrients-10-01727"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Khoury</surname><given-names>D.</given-names></name><name><surname>Balfour-Ducharme</surname><given-names>S.</given-names></name><name><surname>Joye</surname><given-names>I.J.</given-names></name></person-group><article-title>A Review on the Gluten-Free Diet: Technological and Nutritional Challenges</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>1410</elocation-id><pub-id pub-id-type="doi">10.3390/nu10101410</pub-id><?supplied-pmid 30279384?><pub-id pub-id-type="pmid">30279384</pub-id></element-citation></ref><ref id="B38-nutrients-10-01727"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>E.</given-names></name><name><surname>Peters</surname><given-names>S.A.E.</given-names></name><name><surname>Woodward</surname><given-names>M.</given-names></name></person-group><article-title>Sex differences in macronutrient intake and adherence to dietary recommendations: Findings from the UK Biobank</article-title><source>BMJ Open</source><year>2018</year><volume>8</volume><fpage>e020017</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2017-020017</pub-id><?supplied-pmid 29691247?><pub-id pub-id-type="pmid">29691247</pub-id></element-citation></ref><ref id="B39-nutrients-10-01727"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;hn</surname><given-names>L.</given-names></name><name><surname>St&#x000f6;rsrud</surname><given-names>S.</given-names></name><name><surname>Liljebo</surname><given-names>T.</given-names></name><name><surname>Collin</surname><given-names>L.</given-names></name><name><surname>Lindfors</surname><given-names>P.</given-names></name><name><surname>T&#x000f6;rnblom</surname><given-names>H.</given-names></name><name><surname>Simr&#x000e9;n</surname><given-names>M.</given-names></name></person-group><article-title>Diet low in fodmaps reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: A randomized controlled trial</article-title><source>Gastroenterology</source><year>2015</year><volume>149</volume><fpage>1399</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2015.07.054</pub-id><?supplied-pmid 26255043?><pub-id pub-id-type="pmid">26255043</pub-id></element-citation></ref><ref id="B40-nutrients-10-01727"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lonshteyn</surname><given-names>M.</given-names></name><name><surname>Chandar</surname><given-names>A.</given-names></name><name><surname>Falck-Ytter</surname><given-names>Y.</given-names></name></person-group><article-title>Su2061 large effects of a low fodmaps diet in patients with irritable bowel syndrome: A systematic review and meta-analysis</article-title><source>Gastroenterology</source><year>2014</year><volume>146</volume><fpage>S535</fpage><lpage>S536</lpage><pub-id pub-id-type="doi">10.1016/S0016-5085(14)61939-9</pub-id></element-citation></ref><ref id="B41-nutrients-10-01727"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Keeffe</surname><given-names>M.</given-names></name><name><surname>Lomer</surname><given-names>M.C.</given-names></name></person-group><article-title>Who should deliver the low FODMAP diet and what educational methods are optimal: A review</article-title><source>J. Gastroenterol Hepatol</source><year>2017</year><volume>32</volume><issue>Suppl. 1</issue><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/jgh.13690</pub-id><?supplied-pmid 28244661?><pub-id pub-id-type="pmid">28244661</pub-id></element-citation></ref><ref id="B42-nutrients-10-01727"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>S.</given-names></name><name><surname>Sugano</surname><given-names>K.</given-names></name><name><surname>Kinoshita</surname><given-names>Y.</given-names></name><name><surname>Fock</surname><given-names>K.M.</given-names></name><name><surname>Goh</surname><given-names>K.L.</given-names></name><name><surname>Gibson</surname><given-names>P.</given-names></name></person-group><article-title>Diagnosis and treatment of functional gastrointestinal disorders in the asia-pacific region: A survey of current practices</article-title><source>J. Gastroenterol. Hepatol.</source><year>2011</year><volume>26</volume><fpage>2</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2011.06635.x</pub-id><?supplied-pmid 21443699?><pub-id pub-id-type="pmid">21443699</pub-id></element-citation></ref><ref id="B43-nutrients-10-01727"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenhart</surname><given-names>A.</given-names></name><name><surname>Ferch</surname><given-names>C.</given-names></name><name><surname>Shaw</surname><given-names>M.</given-names></name><name><surname>Chey</surname><given-names>W.D.</given-names></name></person-group><article-title>Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists</article-title><source>J. Neurogastroenterol. Motil.</source><year>2018</year><volume>24</volume><fpage>437</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.5056/jnm17116</pub-id><?supplied-pmid 29886578?><pub-id pub-id-type="pmid">29886578</pub-id></element-citation></ref><ref id="B44-nutrients-10-01727"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rej</surname><given-names>A.</given-names></name><name><surname>Avery</surname><given-names>A.</given-names></name><name><surname>Ford</surname><given-names>A.C.</given-names></name><name><surname>Holdoway</surname><given-names>A.</given-names></name><name><surname>Kurien</surname><given-names>M.</given-names></name><name><surname>McKenzie</surname><given-names>Y.</given-names></name><name><surname>Thompson</surname><given-names>J.</given-names></name><name><surname>Trott</surname><given-names>N.</given-names></name><name><surname>Whelan</surname><given-names>K.</given-names></name><name><surname>Williams</surname><given-names>M.</given-names></name><name><surname>Sanders</surname><given-names>D.S.</given-names></name></person-group><article-title>Clinical application of dietary therapies in irritable bowel syndrome</article-title><source>J. Gastrointest. Liver Dis.</source><year>2018</year><volume>27</volume><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.15403/jgld.2014.1121.273.avy</pub-id></element-citation></ref><ref id="B45-nutrients-10-01727"><label>45.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>National Institute for Health and Clinical Excellence</collab></person-group><article-title>Irritable Bowel Syndrome in Adults: Diagnosis and Management</article-title><comment>Clinical Guideline [CG61]</comment><year>2008</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/cg61">https://www.nice.org.uk/guidance/cg61</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2018-10-08">(accessed on 8 October 2018)</date-in-citation></element-citation></ref><ref id="B46-nutrients-10-01727"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>Y.A.</given-names></name><name><surname>Bowyer</surname><given-names>R.K.</given-names></name><name><surname>Leach</surname><given-names>H.</given-names></name><name><surname>Gulia</surname><given-names>P.</given-names></name><name><surname>Horobin</surname><given-names>J.</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>N.A.</given-names></name><name><surname>Pettitt</surname><given-names>C.</given-names></name><name><surname>Reeves</surname><given-names>L.B.</given-names></name><name><surname>Seamark</surname><given-names>L.</given-names></name><name><surname>Williams</surname><given-names>M.</given-names></name><etal/></person-group><article-title>British dietetic association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update)</article-title><source>J. Hum. Nutr. Diet.</source><year>2016</year><volume>29</volume><fpage>549</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1111/jhn.12385</pub-id><?supplied-pmid 27272325?><pub-id pub-id-type="pmid">27272325</pub-id></element-citation></ref><ref id="B47-nutrients-10-01727"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuck</surname><given-names>C.J.</given-names></name><name><surname>Vanner</surname><given-names>S.J.</given-names></name></person-group><article-title>Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions</article-title><source>Neurogastroenterol. Motil.</source><year>2018</year><volume>30</volume><pub-id pub-id-type="doi">10.1111/nmo.13238</pub-id><?supplied-pmid 29094792?><pub-id pub-id-type="pmid">29094792</pub-id></element-citation></ref><ref id="B48-nutrients-10-01727"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whigham</surname><given-names>L.</given-names></name><name><surname>Joyce</surname><given-names>T.</given-names></name><name><surname>Harper</surname><given-names>G.</given-names></name><name><surname>Irving</surname><given-names>P.M.</given-names></name><name><surname>Staudacher</surname><given-names>H.M.</given-names></name><name><surname>Whelan</surname><given-names>K.</given-names></name><name><surname>Lomer</surname><given-names>M.C.E.</given-names></name></person-group><article-title>Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low fodmap diet) in the management of irritable bowel syndrome</article-title><source>J. Hum. Nutr. Diet.</source><year>2015</year><volume>28</volume><fpage>687</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1111/jhn.12318</pub-id><?supplied-pmid 25871564?><pub-id pub-id-type="pmid">25871564</pub-id></element-citation></ref><ref id="B49-nutrients-10-01727"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonder</surname><given-names>M.J.</given-names></name><name><surname>Tigchelaar</surname><given-names>E.F.</given-names></name><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Trynka</surname><given-names>G.</given-names></name><name><surname>Cenit</surname><given-names>M.C.</given-names></name><name><surname>Hrdlickova</surname><given-names>B.</given-names></name><name><surname>Zhong</surname><given-names>H.</given-names></name><name><surname>Vatanen</surname><given-names>T.</given-names></name><name><surname>Gevers</surname><given-names>D.</given-names></name><name><surname>Wijmenga</surname><given-names>C.</given-names></name><etal/></person-group><article-title>The influence of a short-term gluten-free diet on the human gut microbiome</article-title><source>Genome Med.</source><year>2016</year><volume>8</volume><pub-id pub-id-type="doi">10.1186/s13073-016-0295-y</pub-id><?supplied-pmid 27102333?><pub-id pub-id-type="pmid">27102333</pub-id></element-citation></ref><ref id="B50-nutrients-10-01727"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Palma</surname><given-names>G.</given-names></name><name><surname>Nadal</surname><given-names>I.</given-names></name><name><surname>Medina</surname><given-names>M.</given-names></name><name><surname>Donat</surname><given-names>E.</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C.</given-names></name><name><surname>Calabuig</surname><given-names>M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group><article-title>Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children</article-title><source>BMC Microbiol.</source><year>2010</year><volume>10</volume><elocation-id>63</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-10-63</pub-id><?supplied-pmid 20181275?><pub-id pub-id-type="pmid">20181275</pub-id></element-citation></ref><ref id="B51-nutrients-10-01727"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schippa</surname><given-names>S.</given-names></name><name><surname>Iebba</surname><given-names>V.</given-names></name><name><surname>Barbato</surname><given-names>M.</given-names></name><name><surname>Di Nardo</surname><given-names>G.</given-names></name><name><surname>Totino</surname><given-names>V.</given-names></name><name><surname>Checchi</surname><given-names>M.P.</given-names></name><name><surname>Longhi</surname><given-names>C.</given-names></name><name><surname>Maiella</surname><given-names>G.</given-names></name><name><surname>Cucchiara</surname><given-names>S.</given-names></name><name><surname>Conte</surname><given-names>M.P.</given-names></name></person-group><article-title>A distinctive &#x02018;microbial signature&#x02019; in celiac pediatric patients</article-title><source>BMC Microbiol</source><year>2010</year><volume>10</volume><elocation-id>175</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-10-175</pub-id><?supplied-pmid 20565734?><pub-id pub-id-type="pmid">20565734</pub-id></element-citation></ref><ref id="B52-nutrients-10-01727"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Palma</surname><given-names>G.</given-names></name><name><surname>Nadal</surname><given-names>I.</given-names></name><name><surname>Collado</surname><given-names>M.C.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group><article-title>Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects</article-title><source>Br. J. Nutr.</source><year>2009</year><volume>102</volume><fpage>1154</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1017/S0007114509371767</pub-id><?supplied-pmid 19445821?><pub-id pub-id-type="pmid">19445821</pub-id></element-citation></ref><ref id="B53-nutrients-10-01727"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira-Halder</surname><given-names>C.V.</given-names></name><name><surname>Faria</surname><given-names>A.V.S.</given-names></name><name><surname>Andrade</surname><given-names>S.S.</given-names></name></person-group><article-title>Action and function of Faecalibacterium prausnitzii in health and disease</article-title><source>Best Pract. Res. Clin. Gastroenterol.</source><year>2017</year><volume>31</volume><fpage>643</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1016/j.bpg.2017.09.011</pub-id><?supplied-pmid 29566907?><pub-id pub-id-type="pmid">29566907</pub-id></element-citation></ref><ref id="B54-nutrients-10-01727"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swidsinski</surname><given-names>A.</given-names></name><name><surname>Loening-Baucke</surname><given-names>V.</given-names></name><name><surname>Vaneechoutte</surname><given-names>M.</given-names></name><name><surname>Doerffel</surname><given-names>Y.</given-names></name></person-group><article-title>Active crohn&#x002bc;s disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora</article-title><source>Inflamm. Bowel. Dis.</source><year>2008</year><volume>14</volume><fpage>147</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1002/ibd.20330</pub-id><?supplied-pmid 18050295?><pub-id pub-id-type="pmid">18050295</pub-id></element-citation></ref><ref id="B55-nutrients-10-01727"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Mazcorro</surname><given-names>J.F.</given-names></name><name><surname>Noratto</surname><given-names>G.</given-names></name><name><surname>Remes-Troche</surname><given-names>J.M.</given-names></name></person-group><article-title>The Effect of Gluten-Free Diet on Health and the Gut Microbiota Cannot Be Extrapolated from One Population to Others</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>1421</elocation-id><pub-id pub-id-type="doi">10.3390/nu10101421</pub-id><?supplied-pmid 30287726?><pub-id pub-id-type="pmid">30287726</pub-id></element-citation></ref><ref id="B56-nutrients-10-01727"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahnschaffe</surname><given-names>U.</given-names></name><name><surname>Ullrich</surname><given-names>R.</given-names></name><name><surname>Riecken</surname><given-names>E.O.</given-names></name><name><surname>Schulzke</surname><given-names>J.D.</given-names></name></person-group><article-title>Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome</article-title><source>Gastroenterology</source><year>2001</year><volume>121</volume><fpage>1329</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1053/gast.2001.29572</pub-id><?supplied-pmid 11729112?><pub-id pub-id-type="pmid">11729112</pub-id></element-citation></ref><ref id="B57-nutrients-10-01727"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Sabatino</surname><given-names>A.</given-names></name><name><surname>Volta</surname><given-names>U.</given-names></name><name><surname>Salvatore</surname><given-names>C.</given-names></name><name><surname>Biancheri</surname><given-names>P.</given-names></name><name><surname>Caio</surname><given-names>G.</given-names></name><name><surname>De Giorgio</surname><given-names>R.</given-names></name><name><surname>Di Stefano</surname><given-names>M.</given-names></name><name><surname>Corazza</surname><given-names>G.R.</given-names></name></person-group><article-title>Small amounts of gluten in subjects with suspected nonceliac gluten sensitivity: A randomized, double-blind, placebo-controlled, cross-over trial</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2015</year><volume>13</volume><fpage>1604</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2015.01.029</pub-id><?supplied-pmid 25701700?><pub-id pub-id-type="pmid">25701700</pub-id></element-citation></ref><ref id="B58-nutrients-10-01727"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elli</surname><given-names>L.</given-names></name><name><surname>Tomba</surname><given-names>C.</given-names></name><name><surname>Branchi</surname><given-names>F.</given-names></name><name><surname>Roncoroni</surname><given-names>L.</given-names></name><name><surname>Lombardo</surname><given-names>V.</given-names></name><name><surname>Bardella</surname><given-names>M.T.</given-names></name><name><surname>Ferretti</surname><given-names>F.</given-names></name><name><surname>Conte</surname><given-names>D.</given-names></name><name><surname>Valiante</surname><given-names>F.</given-names></name><name><surname>Fini</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Evidence for the Presence of Non-Celiac Gluten Sensitivity in Patients with Functional Gastrointestinal Symptoms: Results from a Multicenter Randomized Double-Blind Placebo-Controlled Gluten Challenge</article-title><source>Nutrients</source><year>2016</year><volume>8</volume><elocation-id>84</elocation-id><pub-id pub-id-type="doi">10.3390/nu8020084</pub-id><?supplied-pmid 26867199?><pub-id pub-id-type="pmid">26867199</pub-id></element-citation></ref><ref id="B59-nutrients-10-01727"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>C.Y.</given-names></name><name><surname>Morris</surname><given-names>J.</given-names></name><name><surname>Whorwell</surname><given-names>P.J.</given-names></name></person-group><article-title>The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress</article-title><source>Aliment. Pharmacol. Ther.</source><year>1997</year><volume>11</volume><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2036.1997.142318000.x</pub-id><?supplied-pmid 9146781?><pub-id pub-id-type="pmid">9146781</pub-id></element-citation></ref><ref id="B60-nutrients-10-01727"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chira</surname><given-names>A.</given-names></name><name><surname>Dumitrascu</surname><given-names>D.L.</given-names></name></person-group><article-title>Serum biomarkers for irritable bowel syndrome</article-title><source>Clujul. Med.</source><year>2015</year><volume>88</volume><fpage>258</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.15386/cjmed-496</pub-id><?supplied-pmid 26609254?><pub-id pub-id-type="pmid">26609254</pub-id></element-citation></ref><ref id="B61-nutrients-10-01727"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Lin</surname><given-names>E.</given-names></name><name><surname>Pimentel</surname><given-names>M.</given-names></name></person-group><article-title>Biomarkers of Irritable Bowel Syndrome</article-title><source>J. Neurogastroenterol. Motil.</source><year>2017</year><volume>23</volume><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.5056/jnm16135</pub-id><?supplied-pmid 27817184?><pub-id pub-id-type="pmid">27817184</pub-id></element-citation></ref><ref id="B62-nutrients-10-01727"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staudacher</surname><given-names>H.M.</given-names></name><name><surname>Irving</surname><given-names>P.M.</given-names></name><name><surname>Lomer</surname><given-names>M.C.E.</given-names></name><name><surname>Whelan</surname><given-names>K.</given-names></name></person-group><article-title>The challenges of control groups, placebos and blinding in clinical trials of dietary interventions</article-title><source>Proc. Nutr. Soc.</source><year>2017</year><volume>76</volume><fpage>628</fpage><pub-id pub-id-type="doi">10.1017/S0029665117002816</pub-id><?supplied-pmid 28854992?><pub-id pub-id-type="pmid">28854992</pub-id></element-citation></ref><ref id="B63-nutrients-10-01727"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>I.</given-names></name><name><surname>Lewis</surname><given-names>N.R.</given-names></name><name><surname>Hadjivassiliou</surname><given-names>M.</given-names></name><name><surname>Winfield</surname><given-names>S.N.</given-names></name><name><surname>Rugg</surname><given-names>N.</given-names></name><name><surname>Kelsall</surname><given-names>A.</given-names></name><name><surname>Newrick</surname><given-names>L.</given-names></name><name><surname>Sanders</surname><given-names>D.S.</given-names></name></person-group><article-title>A uk study assessing the population prevalence of self-reported gluten sensitivity and referral characteristics to secondary care</article-title><source>Eur. J. Gastroenterol. Hepatol.</source><year>2014</year><volume>26</volume><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1097/01.meg.0000435546.87251.f7</pub-id><?supplied-pmid 24216570?><pub-id pub-id-type="pmid">24216570</pub-id></element-citation></ref><ref id="B64-nutrients-10-01727"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanpowpong</surname><given-names>P.</given-names></name><name><surname>Ingham</surname><given-names>T.R.</given-names></name><name><surname>Lampshire</surname><given-names>P.K.</given-names></name><name><surname>Kirchberg</surname><given-names>F.F.</given-names></name><name><surname>Epton</surname><given-names>M.J.</given-names></name><name><surname>Crane</surname><given-names>J.</given-names></name><name><surname>Carmargo</surname><given-names>C.A.</given-names></name></person-group><article-title>Coeliac disease and gluten avoidance in New Zealand children</article-title><source>Arch. Dis. Child.</source><year>2012</year><volume>97</volume><fpage>12</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1136/archdischild-2011-300248</pub-id><?supplied-pmid 22075107?><pub-id pub-id-type="pmid">22075107</pub-id></element-citation></ref><ref id="B65-nutrients-10-01727"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>C.K.</given-names></name><name><surname>Gibson</surname><given-names>P.R.</given-names></name><name><surname>Shepherd</surname><given-names>S.J.</given-names></name></person-group><article-title>Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders</article-title><source>Am. J. Gastroenterol.</source><year>2013</year><volume>108</volume><fpage>748</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1038/ajg.2013.77</pub-id><?supplied-pmid 23609614?><pub-id pub-id-type="pmid">23609614</pub-id></element-citation></ref><ref id="B66-nutrients-10-01727"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>I.</given-names></name><name><surname>Hadjivassiliou</surname><given-names>M.</given-names></name><name><surname>Sanders</surname><given-names>D.S.</given-names></name></person-group><article-title>The spectrum of noncoeliac gluten sensitivity</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2015</year><volume>12</volume><fpage>516</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2015.107</pub-id><?supplied-pmid 26122473?><pub-id pub-id-type="pmid">26122473</pub-id></element-citation></ref><ref id="B67-nutrients-10-01727"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>R.L.</given-names></name><name><surname>Vazquez-Roque</surname><given-names>M.I.</given-names></name><name><surname>Carlson</surname><given-names>P.</given-names></name><name><surname>Burton</surname><given-names>D.</given-names></name><name><surname>Grover</surname><given-names>M.</given-names></name><name><surname>Camilleri</surname><given-names>M.</given-names></name><name><surname>Turner</surname><given-names>J.R.</given-names></name></person-group><article-title>Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression</article-title><source>Lab. Invest.</source><year>2017</year><volume>97</volume><fpage>14</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/labinvest.2016.118</pub-id><?supplied-pmid 27869798?><pub-id pub-id-type="pmid">27869798</pub-id></element-citation></ref><ref id="B68-nutrients-10-01727"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junker</surname><given-names>Y.</given-names></name><name><surname>Zeissig</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S.-J.</given-names></name><name><surname>Barisani</surname><given-names>D.</given-names></name><name><surname>Wieser</surname><given-names>H.</given-names></name><name><surname>Leffler</surname><given-names>D.A.</given-names></name><name><surname>Zevallos</surname><given-names>V.</given-names></name><name><surname>Libermann</surname><given-names>T.A.</given-names></name><name><surname>Dillon</surname><given-names>S.</given-names></name><name><surname>Freitag</surname><given-names>T.L.</given-names></name><etal/></person-group><article-title>Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4</article-title><source>J. Exp. Med.</source><year>2012</year><volume>209</volume><fpage>2395</fpage><lpage>2408</lpage><pub-id pub-id-type="doi">10.1084/jem.20102660</pub-id><?supplied-pmid 23209313?><pub-id pub-id-type="pmid">23209313</pub-id></element-citation></ref><ref id="B69-nutrients-10-01727"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Punder</surname><given-names>K.</given-names></name><name><surname>Pruimboom</surname><given-names>L.</given-names></name></person-group><article-title>The dietary intake of wheat and other cereal grains and their role in inflammation</article-title><source>Nutrients</source><year>2013</year><volume>5</volume><fpage>771</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.3390/nu5030771</pub-id><?supplied-pmid 23482055?><pub-id pub-id-type="pmid">23482055</pub-id></element-citation></ref><ref id="B70-nutrients-10-01727"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiller</surname><given-names>R.</given-names></name></person-group><article-title>How do FODMAPs work?</article-title><source>J. Gastroenterol. Hepatol.</source><year>2017</year><volume>32</volume><issue>Suppl. 1</issue><fpage>36</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1111/jgh.13694</pub-id><?supplied-pmid 28244663?><pub-id pub-id-type="pmid">28244663</pub-id></element-citation></ref><ref id="B71-nutrients-10-01727"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Major</surname><given-names>G.</given-names></name><name><surname>Pritchard</surname><given-names>S.</given-names></name><name><surname>Murray</surname><given-names>K.</given-names></name><name><surname>Alappadan</surname><given-names>J.P.</given-names></name><name><surname>Hoad</surname><given-names>C.L.</given-names></name><name><surname>Marciani</surname><given-names>L.</given-names></name><name><surname>Gowland</surname><given-names>P.</given-names></name><name><surname>Spiller</surname><given-names>R.</given-names></name></person-group><article-title>Colon, Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome</article-title><source>Gastroenterology</source><year>2017</year><volume>152</volume><fpage>124</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2016.09.062</pub-id><?supplied-pmid 27746233?><pub-id pub-id-type="pmid">27746233</pub-id></element-citation></ref><ref id="B72-nutrients-10-01727"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catassi</surname><given-names>C.</given-names></name><name><surname>Alaedini</surname><given-names>A.</given-names></name><name><surname>Bojarski</surname><given-names>C.</given-names></name><name><surname>Bonaz</surname><given-names>B.</given-names></name><name><surname>Bouma</surname><given-names>G.</given-names></name><name><surname>Carroccio</surname><given-names>A.</given-names></name><name><surname>Castillejo</surname><given-names>G.</given-names></name><name><surname>De Magistris</surname><given-names>L.</given-names></name><name><surname>Dieterich</surname><given-names>W.</given-names></name><name><surname>Di Liberto</surname><given-names>D.</given-names></name><etal/></person-group><article-title>The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS)</article-title><source>Nutrients</source><year>2017</year><volume>9</volume><elocation-id>1268</elocation-id><pub-id pub-id-type="doi">10.3390/nu9111268</pub-id><?supplied-pmid 29160841?><pub-id pub-id-type="pmid">29160841</pub-id></element-citation></ref><ref id="B73-nutrients-10-01727"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skodje</surname><given-names>G.I.</given-names></name><name><surname>Sarna</surname><given-names>V.K.</given-names></name><name><surname>Minelle</surname><given-names>I.H.</given-names></name><name><surname>Rolfsen</surname><given-names>K.L.</given-names></name><name><surname>Muir</surname><given-names>J.G.</given-names></name><name><surname>Gibson</surname><given-names>P.R.</given-names></name><name><surname>Veierod</surname><given-names>M.B.</given-names></name><name><surname>Henricksen</surname><given-names>C.</given-names></name><name><surname>Lendin</surname><given-names>K.E.A.</given-names></name></person-group><article-title>Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-reported Non-celiac Gluten Sensitivity</article-title><source>Gastroenterology</source><year>2017</year><volume>154</volume><fpage>529</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2017.10.040</pub-id><?supplied-pmid 29102613?><pub-id pub-id-type="pmid">29102613</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-10-01727-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The spectrum of Gluten Related Disorders. EMA: endomysial antibodies; TTG: tissue transglutaminase; IBS: irritable bowel syndrome; LFD: low fermentable oligo-, di-, and mono- saccharides, and polyols diet; GFD: gluten-free diet; WFD; wheat-free diet.</p></caption><graphic xlink:href="nutrients-10-01727-g001"/></fig><table-wrap id="nutrients-10-01727-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-10-01727-t001_Table 1</object-id><label>Table 1</label><caption><p>The studies evaluating gluten and wheat in Irritable Bowel Syndrome.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Lead Author for Study</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Location</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Number of Participants in Study</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Intervention</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcome</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wahnschaffe [<xref rid="B56-nutrients-10-01727" ref-type="bibr">56</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 months</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">102 patients with IBS-D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gluten-free diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improvement in stool frequency in HLA DQ2/DQ8 positive subjects</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biesiekierski [<xref rid="B21-nutrients-10-01727" ref-type="bibr">21</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Australia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DBPC trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34 patients with IBS symptomatically controlled on gluten-free diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo <italic>n</italic> = 15 Gluten <italic>n</italic> = 19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Worsening of overall symptoms on VAS (<italic>p</italic> = 0.047), as well as pain (<italic>p</italic> = 0.016), bloating (<italic>p</italic> = 0.016), stool consistency (<italic>p</italic> = 0.024) and tiredness (<italic>p</italic> = 0.001) following gluten introduction</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carroccio [<xref rid="B15-nutrients-10-01727" ref-type="bibr">15</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crossover DBPC trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">276 patients with IBS identified as having wheat sensitivity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All participants received wheat or xylose (placebo) capsules</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increase in overall symptoms following the introduction of wheat (<italic>p</italic> &#x0003c; 0.0001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vazquez-Roque [<xref rid="B25-nutrients-10-01727" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Randomised controlled trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45 patients with IBS-D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gluten-containing diet <italic>n</italic> = 22 Gluten-free diet <italic>n</italic> = 23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">More bowel movements per day on a gluten-containing diet (<italic>p</italic> = 0.04)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biesiekierski [<xref rid="B22-nutrients-10-01727" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Australia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crossover DBPC trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-week run in of low FODMAPs then 1 week of high-gluten, low gluten, or placebo for 1 week followed by 2-week washout period</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37 patients with IBS and NCGS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All participants received high gluten, low gluten or placebo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No effect of gluten on GI symptoms</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Di Sabatino [<xref rid="B57-nutrients-10-01727" ref-type="bibr">57</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crossover DBPC trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59 patients with self-reported NCGS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gluten <italic>n</italic> = 30 Placebo <italic>n</italic> = 29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intake of gluten significantly increased overall symptoms compared to placebo (<italic>p</italic> = 0.034)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shahbazkhani [<xref rid="B23-nutrients-10-01727" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iran</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DBPC trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72 patients with IBS on GFD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo <italic>n</italic> = 37 Gluten <italic>n</italic> = 35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Statistically significant worsening of symptoms in the gluten-containing group versus placebo (<italic>p</italic> &#x0003c; 0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aziz [<xref rid="B26-nutrients-10-01727" ref-type="bibr">26</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UK</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41 patients with IBS-D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All participants received GFD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction in mean IBS Symptom Severity Score from 286 to 131 (<italic>p</italic> &#x0003c; 0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zanwar [<xref rid="B24-nutrients-10-01727" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DBPC trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 patients with IBS who responded to GFD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo <italic>n</italic> = 30 Gluten <italic>n</italic> = 30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Worsening of symptoms following intake of gluten (<italic>p</italic> &#x0003c; 0.05)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elli [<xref rid="B58-nutrients-10-01727" ref-type="bibr">58</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crossover DBPC trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-week run in of GFD, followed by randomisation to gluten or placebo for 1 week followed by 1 week washout period</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">140 patients with functional symptoms (77 patients with IBS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo <italic>n</italic> = 48 Gluten <italic>n</italic> = 50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14% of patients who responded to gluten withdrawal noted to have symptomatic relapse during gluten challenge</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Barmeyer [<xref rid="B27-nutrients-10-01727" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 months</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35 patients with IBS-D/M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gluten-free diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34% of participants (<italic>n</italic> = 12) responded to GFD</td></tr></tbody></table><table-wrap-foot><fn><p>DBPC: double-blind placebo-controlled; IBS: irritable bowel syndrome; VAS: visual analogue scale; IBS-D, diarrhoea-predominant IBS; NCGS: non-coeliac gluten sensitivity; GFD: gluten-free diet; FODMAPs: fermentable oligo-, di-, and mono-saccharides, and polyols.</p></fn></table-wrap-foot></table-wrap></floats-group></article>